Sage Journals: Discover world-class research

Abstract

View all access options for this article.

World Medical Association Declaration of Helsinki Ethical principles for medical r e search involving Human subjects, https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/ (accessed 20 October 2020).

Lublin

Reingold

Cohen

, et al. Defining the clinical course of multiple sclerosis. The 2013 revisions. Neurology 2014; 83: 278–286.

Montalban

Gold

Thompson

, et al. ECTRIMS/EAN guideline on the pharmacological treatment of people with multiple sclerosis. Mult Scler 2018; 24: 96–120.

Rio

Any evident MRI T2—lesion activity should guide change of therapy in multiple sclerosis—No. Mult Scler 2015; 21: 132–133.

Giovannoni

Any evident MRI T2—lesion activity should guide change of therapy in multiple sclerosis—Yes. Mult Scler 2015; 21(2): 134–136.

Hutchinson

Any evident MRI T2-lesion activity should guide change of therapy in multiple sclerosis—Commentary. Mult Scler 2015; 21(2): 136–137.

Gasperini

Prosperini

Tintore

, et al. Unraveling treatment response in multiple sclerosis. A clinical and MRI challenge. Neurology 2019; 92: 180–192.